Masloh S - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Enhancing Oral Delivery of Biologics: A Non-Competitive and Cross-Reactive Anti-Leptin Receptor Nanofitin Demonstrates a Gut-Crossing Capacity in an Ex Vivo Porcine Intestinal Model.

Masloh S, Chevrel A, Culot M, Perrocheau A, Kalia YN, Frehel S, Gaussin R, Gosselet F, Huet S, Zeisser Labouebe M, Scapozza L. Masloh S, et al. Pharmaceutics. 2024 Jan 16;16(1):116. doi: 10.3390/pharmaceutics16010116. Pharmaceutics. 2024. PMID: 38258126 Free PMC article.

Challenges and Opportunities in the Oral Delivery of Recombinant Biologics.

Masloh S, Culot M, Gosselet F, Chevrel A, Scapozza L, Zeisser Labouebe M. Masloh S, et al. Pharmaceutics. 2023 May 5;15(5):1415. doi: 10.3390/pharmaceutics15051415. Pharmaceutics. 2023. PMID: 37242657 Free PMC article. Review.

Impact of naturally occurring variation in the human papillomavirus 52 capsid proteins on recognition by type-specific neutralising antibodies.

Godi A, Bissett SL, Masloh S, Fleury M, Li S, Zhao Q, Xia N, Cocuzza CE, Beddows S. Godi A, et al. Among authors: masloh s. J Gen Virol. 2019 Feb;100(2):237-245. doi: 10.1099/jgv.0.001213. Epub 2019 Jan 18. J Gen Virol. 2019. PMID: 30657447

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters